Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Change in Account Payables (2016 - 2025)

Aethlon Medical (AEMD) has disclosed Change in Account Payables for 15 consecutive years, with -$202334.0 as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, Change in Account Payables fell 84.59% year-over-year to -$202334.0, compared with a TTM value of $33131.0 through Mar 2025, down 90.03%, and an annual FY2025 reading of $33131.0, down 90.03% over the prior year.
  • Change in Account Payables was -$202334.0 for Q1 2025 at Aethlon Medical, up from -$229645.0 in the prior quarter.
  • Across five years, Change in Account Payables topped out at $406264.0 in Q4 2023 and bottomed at -$229645.0 in Q4 2024.
  • Average Change in Account Payables over 5 years is $26342.3, with a median of $12870.0 recorded in 2022.
  • The sharpest move saw Change in Account Payables crashed 2771.92% in 2021, then soared 3056.67% in 2023.
  • Year by year, Change in Account Payables stood at -$3832.0 in 2021, then skyrocketed by 435.86% to $12870.0 in 2022, then skyrocketed by 3056.67% to $406264.0 in 2023, then crashed by 156.53% to -$229645.0 in 2024, then increased by 11.89% to -$202334.0 in 2025.
  • Business Quant data shows Change in Account Payables for AEMD at -$202334.0 in Q1 2025, -$229645.0 in Q4 2024, and $279026.0 in Q3 2024.